
    
      This double-blinded randomized clinical trial investigates difference in allergic responses
      elicited by Bee Venom (BV) and Essential Bee Venom (eBV). Twenty healthy volunteers aged
      20-40 years were randomly allocated to the 2 groups and administered eBV and BV on left and
      right forearm, respectively, in accordance with group allocation. Physician, participant, and
      outcome assessor were blinded to group allocation. Local pain, swelling, itching, redness,
      wheals and adverse reactions were recorded by timepoint before and after treatment.
    
  